SCHEMBL30755336

SCHEMBL30755336

Cc1c(C(F)(F)F)ccc(I)c1C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TAS2R14 Q9NYV8 2/20 0.41
▸ DAO P14920 2/20 0.38
▸ DHODH Q02127 3/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ NOTUM Q6P988 2/20 0.35
▸ ASPH Q12797 1/20 0.34
▸ CFTR P13569 1/20 0.33
▸ CES2 O00748 1/20 0.33
▸ SORT1 Q99523 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ KMO O15229 1/20 0.33
▸ PTGFR P43088 1/20 0.32
▸ PLK1 P53350 1/20 0.32
▸ PLK3 Q9H4B4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27379121 1.00 TAS2R14 (0.41) TAS2R14DAODHODHHDAC6ALDH1A1
SCHEMBL6731917 0.80 DAO (0.43) DAOHDAC6ALDH1A1HPGDNOTUM
SCHEMBL22208710 0.80 TAS2R14 (0.42) TAS2R14DAODHODHHDAC6ALDH1A1
SCHEMBL30755194 0.79 NR1H2 (0.40) TAS2R14HDAC6NOTUMCFTRCES2
SCHEMBL24040210 0.78 PDE10A (0.37) DHODHALDH1A1NOTUMSMN1; SMN2
SCHEMBL1534127 0.76 CA12 (0.50) TAS2R14ALDH1A1HPGDLMNAHTT
SCHEMBL14352206 0.76 FABP3 (0.40) DAONOTUMSMN1; SMN2
SCHEMBL10598245 0.75 METAP2 (0.41) DHODHALDH1A1NOTUMLMNASMN1; SMN2
SCHEMBL6677822 0.75 TAS2R14 (0.44) TAS2R14DHODHALDH1A1HPGDKMO
SCHEMBL31404957 0.73 KIF11 (0.32) TAS2R14NOTUMCFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4562016-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME Cedilla Therapeutics, Inc. (US) 2025-06-04 — — EP disclosed
WO-2024026483-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback